LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay

Parkinsonism and Related Disorders

Volumn 15, Issue 5, 2009, Pages 370-373

  Mata, Ignacio F ^a,b   Cosentino, Carlos ^c   Marca, Victoria ^c   Torres, Luis ^c   Mazzetti, Pilar ^c   Ortega, Olimpio ^c   Raggio, Victor ^d   Aljanati, Ruth ^d   Buzó, Ricardo ^d   Yearout, Dora ^a,b   Dieguez, Elena ^d   Zabetian, Cyrus P ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^d DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

Haplotype; LRRK2; Mutation; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LEVODOPA;

ADULT; AGED; ARTICLE; DEMENTIA; DISEASE DURATION; ETHNICITY; FAMILY HISTORY; FEMALE; GENE MUTATION; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PERU; PREVALENCE; PRIORITY JOURNAL; TREATMENT RESPONSE; URUGUAY;

AMINO ACID SUBSTITUTION; CARRIER STATE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENETIC MARKERS; GENETIC VARIATION; HUMANS; MALE; MEDICAL HISTORY TAKING; PARKINSON DISEASE; PERU; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; URUGUAY;

EID: 67349203890     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.09.002     Document Type: Article

References (28)

1. de Rijk M.C., Tzourio C., Breteler M.M., Dartigues J.F., Amaducci L., Lopez-Pousa S., et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON collaborative study. European community concerted action on the epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatr 62 (1997) 10-15
2. Pankratz N., and Foroud T. Genetics of Parkinson disease. Genet Med 9 (2007) 801-811
3. Gasser T. Update on the genetics of Parkinson's disease. Mov Disord 22 Suppl. 17 (2007) S343-S350
4. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354 (2006) 422-423
5. Tan E.K., Shen H., Tan L.C., Farrer M., Yew K., Chua E., et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 384 (2005) 327-329
6. Zabetian C.P., Morino H., Ujike H., Yamamoto M., Oda M., Maruyama H., et al. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Neurology 67 (2006) 697-699
7. Goldwurm S., Di Fonzo A., Simons E.J., Rohe C.F., Zini M., Canesi M., et al. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet 42 (2005) e65
8. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76 (2005) 672-680
9. Kay D.M., Zabetian C.P., Factor S.A., Nutt J.G., Samii A., Griffith A., et al. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Mov Disord 21 (2006) 519-523
10. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 (2005) 410-412
11. Gonzalez-Fernandez M.C., Lezcano E., Ross O.A., Gomez-Esteban J.C., Gomez-Busto F., Velasco F., et al. Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain. Parkinsonism Relat Disord 422 (2007) 193-197
12. Simon-Sanchez J., Marti-Masso J.F., Sanchez-Mut J.V., Paisan-Ruiz C., Martinez-Gil A., Ruiz-Martinez J., et al. Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques. Mov Disord 21 (2006) 1954-1959
13. Deng H., Le W., Guo Y., Hunter C.B., Xie W., Huang M., et al. Genetic analysis of LRRK2 mutations in patients with Parkinson disease. J Neurol Sci 251 (2006) 102-106
14. Gibb W.R., and Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatr 51 (1988) 745-752
15. Zabetian C.P., Hutter C.M., Yearout D., Lopez A.N., Factor S.A., Griffith A., et al. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 79 (2006) 752-758
16. Mata I.F., Taylor J.P., Kachergus J., Hulihan M., Huerta C., Lahoz C., et al. LRRK2 R1441G in Spanish patients with Parkinson's disease. Neurosci Lett 382 (2005) 309-311
17. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
18. Munhoz R.P., Wakutani Y., Marras C., Teive H.A., Raskin S., Werneck L.C., et al. The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: phenotype in monozygotic twins. Mov Disord 23 (2008) 290-294
19. Perez-Pastene C., Cobb S.A., Diaz-Grez F., Hulihan M.M., Miranda M., Venegas P., et al. Lrrk2 mutations in South America: a study of Chilean Parkinson's disease. Neurosci Lett 422 (2007) 193-197
20. Pimentel M.M., Moura K.C., Abdalla C.B., Pereira J.S., de Rosso A.L., Nicaretta D.H., et al. A study of LRRK2 mutations and Parkinson's disease in Brazil. Neurosci Lett 433 (2008) 17-21
21. Civitelli D., Tarantino P., Nicoletti G., Ciro Candiano I.C., Annesi F., De Marco E.V., et al. LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease. Clin Genet 71 (2007) 367-370
22. Gaig C., Ezquerra M., Marti M.J., Munoz E., Valldeoriola F., and Tolosa E. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 63 (2006) 377-382
23. Infante J., Rodriguez E., Combarros O., Mateo I., Fontalba A., Pascual J., et al. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease. Neurosci Lett 395 (2006) 224-226
24. Mata I.F., Ross O.A., Kachergus J., Huerta C., Ribacoba R., Moris G., et al. LRRK2 mutations are a common cause of Parkinson's disease in Spain. Eur J Neurol 13 (2006) 391-394
25. Healy D.G., Falchi M., O'Sullivan S.S., Bonifati V., Durr A., Bressman S., et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7 (2008) 583-590
26. Central Intelligence Agency. The World factbook. Washington, DC (2008). https://www.cia.gov/library/publications/the-world-factbook/index.html
27. Haugarvoll K., Rademakers R., Kachergus J.M., Nuytemans K., Ross O.A., Gibson J.M., et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70 (2008) 1456-1460
28. Ross OA, Spanaki C, Griffith A, Lin C-H, Kachergus J, Haugarvoll, K, et al. Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. Parkinsonism and Related Disorders, in press, doi:10.1016/j.parkreldis.2008.09.001.